Coapt Systems

company

About

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$12.20M
Industries
Biotechnology,Cosmetic Surgery,Manufacturing,Marketing
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous

The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$18.50M
Coapt Systems has raised a total of $18.50M in funding over 2 rounds. Their latest funding was raised on Feb 7, 2003 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 7, 2003 Series C $12.20M 2 Detail
Jan 4, 2002 Series B $6.30M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Coapt Systems is funded by 2 investors. Pacific Asset Partners and Trellis Health Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Pacific Asset Partners Series C
Trellis Health Ventures Series C